Neutral
●
GlobeNewsWire
●
6 months ago
SARASOTA, Fla. and PARIS, March 30, 2026 (GLOBE NEWSWIRE) -- Hope Therapeutics, Inc. (“Hope”), a subsidiary of NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), today announced a strategic partnership with Emobot Health to deploy its revolutionary AI-driven emotional monitoring platform across Hope's rapidly expanding network of interventional psychiatry clinics. This roll-out represents the first larg...